Prostatype Genomics AB (publ) (STO:PROGEN)
Sweden · Delayed Price · Currency is SEK 1.130
+0.278 (32.63%)
Mar 4, 2026, 5:29 PM CET
Prostatype Genomics AB Revenue
In the year 2025, Prostatype Genomics AB had annual revenue of 597.00K SEK, down -68.87%. Prostatype Genomics AB had revenue of 246.00K in the half year ending June 30, 2025, a decrease of -76.81%.
Revenue
597.00K
Revenue Growth
-68.87%
P/S Ratio
112.60
Revenue / Employee
99.00K
Employees
6
Market Cap
66.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 597.00K | -1.32M | -68.87% |
| Dec 31, 2024 | 1.92M | -1.81M | -48.55% |
| Dec 31, 2023 | 3.73M | 3.05M | 445.83% |
| Dec 31, 2022 | 683.00K | -1.83M | -72.78% |
| Dec 31, 2021 | 2.51M | -498.13K | -16.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.97B |
| Swedish Orphan Biovitrum AB | 28.24B |
| Medicover AB | 25.74B |
| Sectra AB | 3.47B |
| ScandiDos AB | 61.26M |
| Alzinova AB | 26.12M |
| Luxbright AB | 13.75M |
| ExpreS2ion Biotech Holding AB | 10.85M |